Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloproliferative neopl

• 作 者: 刘贵敏
• 机 构: Dept Hematol,Baoding No.1 Hosp,
• 出 处: China Medical Abstracts(Internal Medicine)
• 发表日期: 2017年02期
• 关键词: neoplasms migration chambers inhib manner enrolled mutation

Objective To investigate the regulation of JAK2tyrosine kinase inhibitor ruxolitinib on extracellular matrix metalloproteinase(MMP in JAK2V61F positive myeloproliferative neoplasms(MPN)cells.Methods(1)Forty cases of newly diagnosed JAK2V617F positive MPN patients and 15 healthy volunteers as control in Baoding NO.1 Hospital between January 2012 and December

Objective To investigate the regulation of JAK2 tyrosine kinase inhibitor ruxolitinib on extracellular matrix metalloproteinase (MMP in JAK2V61F positive myeloproliferative neoplasms (MPN) cells. Methods (1) Forty cases of newly diagnosed JAK2V617F positive MPN patients and 15 healthy volunteers as control in Baoding NO.1 Hospital between January 2012 and December